scholarly journals Impact of Chronic Kidney Disease and Anemia on Physical Function in Patients with Chronic Heart Failure

2014 ◽  
Vol 4 (2) ◽  
pp. 73-81 ◽  
Author(s):  
Masakazu Saitoh ◽  
Haruki Itoh ◽  
Nobuo Morotomi ◽  
Tetsuya Ozawa ◽  
Noriko Ishii ◽  
...  
Keyword(s):  
Heart Failure ◽  
Chronic Kidney Disease ◽  
Chronic Heart Failure ◽  
Kidney Disease ◽  
Physical Function

Abstract 17220: Effects of the Oral Adsorbent of AST-120 in Patients with both Chronic Heart Failure and Chronic Kidney Disease

Circulation ◽  
2014 ◽  
Vol 130 (suppl_2) ◽  
Author(s):  
Miki Imazu ◽  
Masanori Asakura ◽  
Takuya Hasegawa ◽  
Hiroshi Asanuma ◽  
Shin Ito ◽  
...  
Keyword(s):  
Heart Failure ◽  
Chronic Kidney Disease ◽  
Chronic Heart Failure ◽  
Kidney Disease ◽  
Diastolic Dysfunction ◽  
Uremic Toxins ◽  
Control Group ◽  
Blood Levels ◽  
Uremic Toxin ◽  
Oral Adsorbent

Background: One of uremic toxins, indoxyl sulfate (IS) is related to the progression of chronic kidney disease (CKD) and the worse cardiovascular outcomes. We have previously reported the relationship between IS levels and the severity of chronic heart failure (CHF), but the question arises as to whether the treatment of uremic toxin is beneficial in patients with CHF. This study aimed to elucidate whether the treatment with the oral adsorbent which reduces uremic toxin improved the cardiac function of the patients with CHF. Methods: First of all, we retrospectively enrolled 49 patients with both CHF and stage ≤3 CKD in our institute compared with the healthy subjects without CHF or CKD in the resident cohort study of Arita. Secondly, we retrospectively enrolled 16 CHF outpatients with stage 3-5 CKD. They were treated with and without the oral adsorbent of AST-120 for one year termed as the treatment and control groups, respectively. We underwent both blood test and echocardiography before and after the treatment. Results: First of all, among 49 patients in CHF patients, plasma IS levels increased to 1.38 ± 0.84 μg/ml from the value of 0.08 ± 0.06 μg/ml in Arita-cho as a community-living matched with gender and eGFR of CHF patients. We found both fractional shortening (FS) and E/e’, an index of diastolic function were decreased (25.0 ± 12.7%) and increased (13.7 ± 7.5), respectively in CHF patients compared with the value of FS and E/e’ in Arita-cho (FS: 41.8 ± 8.3%, E/e’: 8.8 ± 2.1). Secondly, in the treatment group, the plasma IS levels and the serum creatinine and brain natriuretic peptide levels decreased (1.40 ± 0.17 to 0.92 ± 0.15 μg/ml; p<0.05, 1.91 ± 0.16 to 1.67 ± 0.12 mg/dl; p<0.05, 352 ± 57 to 244 ± 49 pg/ml; p<0.05, respectively) and both FS and E/e’ were improved following the treatment with AST-120 (28.8 ± 2.8 to 32.9 ± 2.6%; p<0.05, 18.0 ± 2.0 to 11.8 ± 1.0; p<0.05). However, these parameters did not change in the control group. Conclusions: The treatment to decrease the blood levels of uremic toxins improved not only renal dysfunction but cardiac systolic and diastolic dysfunction in patients with chronic heart failure. Oral adsorbents might be a new treatment of heart failure especially with diastolic dysfunction.

Renal arterial pulsatility predicts progression of chronic kidney disease in chronic heart failure patients

2013 ◽  
Vol 167 (6) ◽  
pp. 3050-3051 ◽  
Author(s):  
Mariantonietta Cicoira ◽  
Luca Conte ◽  
Andrea Rossi ◽  
Stefano Bonapace ◽  
Giulia D'Agostini ◽  
...  
Keyword(s):  
Heart Failure ◽  
Chronic Kidney Disease ◽  
Chronic Heart Failure ◽  
Kidney Disease ◽  
Heart Failure Patients

scholarly journals Prognostic Importance of Chronic Kidney Disease in Japanese Patients With Chronic Heart Failure

2008 ◽  
Vol 72 (2) ◽  
pp. 173-178 ◽  
Author(s):  
Nobuyuki Shiba ◽  
Mika Matsuki ◽  
Jun Takahashi ◽  
Tomohiro Tada ◽  
Jun Watanabe ◽  
...  
Keyword(s):  
Heart Failure ◽  
Chronic Kidney Disease ◽  
Chronic Heart Failure ◽  
Kidney Disease ◽  
Japanese Patients ◽  
Prognostic Importance

scholarly journals Effects of tolvaptan in patients with chronic kidney disease and chronic heart failure

2017 ◽  
Vol 21 (5) ◽  
pp. 858-865 ◽  
Author(s):  
Mari Katsumata ◽  
Nobuhito Hirawa ◽  
Koichiro Sumida ◽  
Minako Kagimoto ◽  
Yosuke Ehara ◽  
...  
Keyword(s):  
Heart Failure ◽  
Chronic Kidney Disease ◽  
Chronic Heart Failure ◽  
Kidney Disease
Sign in / Sign up

Export Citation Format

Share Document